• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于模型的稳健 JAK-STAT 激活机制选择。

Model-based selection of the robust JAK-STAT activation mechanism.

机构信息

Institute of Informatics, University of Warsaw, ul. Banacha 2, Warsaw, Poland.

出版信息

J Theor Biol. 2012 Sep 21;309:34-46. doi: 10.1016/j.jtbi.2012.04.031. Epub 2012 Jun 5.

DOI:10.1016/j.jtbi.2012.04.031
PMID:22677400
Abstract

JAK-STAT pathway family is a principal signaling mechanism in eukaryotic cells. Evolutionary conserved roles of this mechanism include control over fundamental processes such as cell growth or apoptosis. Deregulation of the JAK-STAT signaling is frequently associated with cancerogenesis. JAK-STAT pathways become hyper-activated in many human tumors. Therefore, components of these pathways are an attractive target for drugs, which design requires as adequate models as possible. Although, in principle, JAK-STAT signaling is relatively simple, the ambiguities in a receptor activation prevent a clear explanation of the underlying molecular mechanism. Here, we compare four variants of a computational model of the JAK1/2-STAT1 signaling pathway. These variants capture known, basic discrepancies in the mechanism of activation of a cytokine receptor, in the context of all key components of the pathway. We carry out a comparative analysis using mass action kinetics. The investigated differences are so marginal that all models satisfy a goodness of fit criteria to the extent that the state of the art Bayesian model selection (BMS) method fails to significantly promote one model. Therefore, we comparatively investigate changes in a robustness of the JAK1/2-STAT1 pathway variants using the global sensitivity analysis method (GSA), complemented with the identifiability analysis (IA). Both BMS and GSA are used to analyze the models for the varying parameter values. We found out that, both BMS and GSA, narrowed down to the receptor activation component, slightly promote the least complex model. Further, insightful, comprehensive GSA, motivated by the concept of robustness, allowed us to show that the precise order of reactions of a ligand binding and a receptor dimerization is not as important as the on-membrane pre-assembly of the dimers in the absence of ligand. The main value of this work is an evaluation of the usefulness of different model selection methods in a frequently encountered, but not much discussed case of a model of a considerable size, which has several variants differing at peripheries. In such situation, all considered variants can reach nearly perfect agreement with respect to their numerical simulations results and, most often, the sufficient experimental data to test against is not available. We argue that in such an adverse setting, the GSA and IA, although not directly corresponding to the model selection problem, can be more informative than the representative, generalizability-based approaches to this task. An additional insight into how the responsibility for the network dynamics spreads among model parameters, enables more conscious, expert-mediated choice of the preferred model.

摘要

JAK-STAT 通路家族是真核细胞中主要的信号转导机制。该机制的进化保守作用包括控制细胞生长或凋亡等基本过程。JAK-STAT 信号的失调经常与癌症发生有关。JAK-STAT 通路在许多人类肿瘤中过度激活。因此,这些通路的成分是药物设计的一个有吸引力的靶点,这需要尽可能好的模型。尽管 JAK-STAT 信号在原则上相对简单,但受体激活的不明确性阻止了对潜在分子机制的清晰解释。在这里,我们比较了 JAK1/2-STAT1 信号通路的四种计算模型变体。这些变体捕获了细胞因子受体激活机制中的已知基本差异,同时考虑了通路的所有关键成分。我们使用质量作用动力学进行了比较分析。研究的差异非常微小,以至于所有模型都满足拟合度标准,以至于最先进的贝叶斯模型选择 (BMS) 方法无法显著促进一个模型。因此,我们使用全局敏感性分析方法 (GSA) 比较研究了 JAK1/2-STAT1 通路变体的稳健性变化,并辅以可识别性分析 (IA)。BMS 和 GSA 都用于分析模型的变化参数值。我们发现,BMS 和 GSA 都缩小到受体激活组件,稍微促进最简单的模型。此外,深入的、全面的 GSA,由稳健性的概念驱动,使我们能够表明,配体结合和受体二聚化的反应顺序并不像在没有配体的情况下,二聚体在膜上的预组装那样重要。这项工作的主要价值是评估不同模型选择方法在一种经常遇到但讨论不多的情况下的有用性,即模型尺寸相当大,并且有几个变体在边缘处不同。在这种情况下,所有考虑的变体都可以在其数值模拟结果方面达到几乎完美的一致,并且通常情况下,没有足够的实验数据来进行测试。我们认为,在这种不利的情况下,尽管 GSA 和 IA 与模型选择问题没有直接对应,但与代表性的、基于通用性的方法相比,它们可以提供更多的信息。对网络动态的责任如何在模型参数之间传播的深入了解,可以使更有意识、更专业的选择首选模型成为可能。

相似文献

1
Model-based selection of the robust JAK-STAT activation mechanism.基于模型的稳健 JAK-STAT 激活机制选择。
J Theor Biol. 2012 Sep 21;309:34-46. doi: 10.1016/j.jtbi.2012.04.031. Epub 2012 Jun 5.
2
Dynamics and non-canonical aspects of JAK/STAT signalling.JAK/STAT 信号转导的动力学和非经典方面。
Eur J Cell Biol. 2012 Jun-Jul;91(6-7):524-32. doi: 10.1016/j.ejcb.2011.09.005. Epub 2011 Oct 21.
3
Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.胰岛素样生长因子-I受体信号转导与Janus激酶/信号转导子和转录激活子(JAK-STAT)通路。
Biofactors. 2009 Jan-Feb;35(1):76-81. doi: 10.1002/biof.20.
4
Model-driven experimental analysis of the function of SHP-2 in IL-6-induced Jak/STAT signaling.SHP-2在白细胞介素-6诱导的Jak/STAT信号传导中功能的模型驱动实验分析
Mol Biosyst. 2012 Aug;8(8):2119-34. doi: 10.1039/c2mb05488d. Epub 2012 Jun 19.
5
Inhibition of JAK/STAT signaling pathway prevents high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells.抑制 JAK/STAT 信号通路可防止高糖诱导的人内皮细胞内皮素-1 合成增加。
Cell Tissue Res. 2010 Apr;340(1):71-9. doi: 10.1007/s00441-010-0936-1. Epub 2010 Mar 9.
6
JAK/STAT signaling coordinates stem cell proliferation and multilineage differentiation in the Drosophila intestinal stem cell lineage.JAK/STAT 信号通路协调果蝇肠道干细胞系中的干细胞增殖和多能性分化。
Dev Biol. 2010 Feb 1;338(1):28-37. doi: 10.1016/j.ydbio.2009.10.045. Epub 2009 Nov 6.
7
Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.B细胞抗原受体的激活通过Lyn在一条不依赖Jak的途径中激活STAT。
Oncogene. 2007 May 3;26(20):2851-9. doi: 10.1038/sj.onc.1210092. Epub 2006 Dec 4.
8
JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.JAK/STAT 通路在由 DON 和 T-2 毒素等单端孢霉烯诱导的 RAW264.7 细胞的促炎基因表达和细胞凋亡中起着关键作用。
Toxicol Sci. 2012 Jun;127(2):412-24. doi: 10.1093/toxsci/kfs106. Epub 2012 Mar 27.
9
Systems biology of JAK/STAT signalling.JAK/STAT信号传导的系统生物学
Essays Biochem. 2008;45:109-20. doi: 10.1042/BSE0450109.
10
Mining for JAK-STAT mutations in cancer.挖掘癌症中的JAK-STAT突变
Trends Biochem Sci. 2008 Mar;33(3):122-31. doi: 10.1016/j.tibs.2007.12.002.

引用本文的文献

1
Stochastic dynamics of Type-I interferon responses.I 型干扰素反应的随机动力学。
PLoS Comput Biol. 2022 Oct 21;18(10):e1010623. doi: 10.1371/journal.pcbi.1010623. eCollection 2022 Oct.
2
Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.淫羊藿素:血液系统恶性肿瘤治疗的新型天然候选药物。
Biomed Res Int. 2019 Mar 28;2019:4860268. doi: 10.1155/2019/4860268. eCollection 2019.
3
Computational models of the JAK1/2-STAT1 signaling.JAK1/2-STAT1信号传导的计算模型。
JAKSTAT. 2013 Jul 1;2(3):e24672. doi: 10.4161/jkst.24672. Epub 2013 Apr 15.
4
Bioinformatics and computational biology in Poland.波兰的生物信息学与计算生物学
PLoS Comput Biol. 2013;9(5):e1003048. doi: 10.1371/journal.pcbi.1003048. Epub 2013 May 2.
5
Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease.经无标记蛋白质组学分析慢性心房颤动合并二尖瓣疾病患者的心房纤维化蛋白。
PLoS One. 2013 Apr 4;8(4):e60210. doi: 10.1371/journal.pone.0060210. Print 2013.